Accelrys Posts 1 Percent Dip in Fiscal Q1 Revenues | GenomeWeb

NEW YORK (GenomeWeb News) – Accelrys yesterday reported a 1 percent decline in revenues for its first fiscal quarter as its net income improved over the year-ago period.

Accelrys said that revenues for the three months ended June 30 decreased to $20.1 million from $20.3 million in the prior-year period. The company attributed the decrease to a drop in maintenance revenue of around $400,000, which was partially offset by an increase in software revenue of around $300,000.

Net income increased to $744,000 from $86,000 in the comparable period of 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.